Table 3 Crystalloids, blood components, urinary excretion, coagulation products and catecholamine from the anesthetic induction till the end of surgery (phase 1)
variable | 6% HES 130/0.42 (n = 30) | 4% gelatin (n = 30) | 6% HES 200/0.5 (n = 30) | p-value |
|---|---|---|---|---|
saline (ml) ± SD | 2008 ± 476 | 2028 ± 799 | 2007 ± 357 | > 0.2 |
other crystalloides (ml) ± SD | 1318 ± 265 | 1289 ± 326 | 1231 ± 423 | > 0.2 |
red cell concentrate (n) ± SD | 3 ± 1 | 3 ± 2 | 3 ± 1 | > 0.2 |
fresh frozen plasma (n) ± SD | 4 ± 1 | 3 ± 1 | 3 ± 1 | > 0.2 |
platelet concentrate (n) ± SD | 2 ± 1 | 2 ± 1 | 2 ± 0.0 | > 0.2 |
bicarbonate 8.4% (ml) ± SD | 46 ± 21 | 48 ± 31 | 47 ± 22 | > 0.2 |
urinary excretion (ml) ± SD | 421 ± 245 | 570 ± 356 | 690 ± 468 | < 0.05 |
aprotinine (mE) ± SD | 1 ± 1 | 2 ± 1 | 2 ± 1 | < 0.05 |
heparine (IE) ± SD | 37250 ± 8914 | 38167 ± 7484 | 37833 ± 6914 | > 0.2 |
protamine (IE) ± SD | 34500 ± 6991 | 37500 ± 7399 | 36167 ± 6783 | > 0.2 |
norepinephrine (mg) ± SD | 1 ± 1 | 1 ± 1 | 2 ± 1 | 0.1275 |
dobutamine (mg) ± SD | 26 ± 10 | 28 ± 20 | 25 ± 6 | > 0.2 |